CME News Alert CME Group Inc (CME) 87.08 12/13/2014 06:09:23

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
CME Group Inc (CME) 87.08 $CME

Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Class Action Has Been Filed on Behalf of Sellers of GFI Group Inc. Common Stock
GlobeNewswire - Fri Dec 12, 6:00PM CST
Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who sold GFI Group Inc. ("GFI" or the "Company" common stock (Symbol: GFIG) on the New York Stock Exchange ("NYSE" during the period between July 30, 2014 and September 8, 2014. The deadline to move for Lead Plaintiff status is January 26, 2015.
GFIG: 5.39 (-0.11), CME: 87.08 (-1.40)

CME Group Rewards Shareholders with Variable Dividend - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 3:20PM CST
CME Group Inc. (CME) recently announced a special annual variable dividend of $2.00 per share.
CME: 87.08 (-1.40), CBOE: 62.34 (-1.19), ICE: 219.09 (-6.36), NDAQ: 46.11 (-0.86)

CBOE Hits New 52-Week High as Volatility Index Escalates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 1:50PM CST
Shares of CBOE Holdings Inc. (CBOE) scaled a new 52-week high of $63.66 on Dec 10, 2014.
MKTX: 68.45 (-1.34), CME: 87.08 (-1.40), CBOE: 62.34 (-1.19), ICE: 219.09 (-6.36)

CME price target upped after special payout
Seeking Alpha - at Seeking Alpha - Thu Dec 11, 10:32AM CST

CME: 87.08 (-1.40)

CME declares $2.00 dividend
Seeking Alpha - at Seeking Alpha - Thu Dec 11, 5:23AM CST

CME: 87.08 (-1.40)

CME Group announces USD2.00 per share annual variable dividend
M2 - Thu Dec 11, 3:43AM CST
CME Group Inc (NASDAQ:CME), a provider of diverse derivatives electronic trading exchanges, declared on Thursday that its annual variable dividend is USD2.00 per share, or a total of over USD673m.
CME: 87.08 (-1.40)

CME Group Inc. Declares Annual Variable Dividend of $2.00 per Share
PR Newswire - Wed Dec 10, 6:13PM CST
CME Group Inc. (NASDAQ: CME) today declared its annual variable dividend, amounting to $2.00 per share. The dividend is payable January 13, 2015, to shareholders of record on December 29, 2014. When CME Group adopted its annual variable dividend structure in February 2012, the intention was to determine the excess cash available at the end of each year, with the level to increase or decrease from year to year based on operating results, potential investment activity and other forms of capital return.
CME: 87.08 (-1.40)

CME Group Wins Multiple Categories at the FOW International Awards
PR Newswire - Wed Dec 10, 3:30AM CST
CME Group, the world's leading and most diverse derivatives marketplace, today announced that it has won four categories at the FOW International Awards:
CME: 87.08 (-1.40)

ICE in Final Leg of Euronext Exit, to Gain from Stock Rally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 4:30PM CST
Intercontinental Exchange Inc. (ICE) has decided to vend of the remaining 4.2 million shares in in Euronext NV.
CME: 87.08 (-1.40), CBOE: 62.34 (-1.19), ICE: 219.09 (-6.36), NDAQ: 46.11 (-0.86)

CME Group Announces First Trades of New Iron Ore Futures Contract
PR Newswire - Tue Dec 09, 9:51AM CST
CME Group, the world's leading and most diverse derivatives marketplace, today announced the first Iron Ore 58% Fe, Low Alumina, CFR China (TSI) Futures contracts were cleared on 8 December 2014, through CME ClearPort. The first trade was executed between Caravel Metallurgical Ltd and a large international trading house, and brokered by GFI Group. A total of 20 lots traded in the January 2015 contract on 8 December.
CME: 87.08 (-1.40)

CME Group Chief Executive Officer to Present at Goldman Sachs Conference December 9
PR Newswire - Mon Dec 08, 10:47AM CST
CME Group announced today that Chief Executive Officer Phupinder Gill will present at the Goldman Sachs US Financial Services Conference 2014, in New York, on Tuesday, December 9, 2014, at 2:00 p.m. (Eastern Time).
CME: 87.08 (-1.40)

CME Group Inc. Announces Date of Fourth-Quarter 2014 Earnings Release, Conference Call
PR Newswire - Mon Dec 08, 8:00AM CST
CME Group Inc. will announce earnings for the fourth quarter of 2014 before the markets open on Tuesday, February 3, 2015. The company has scheduled an investor conference call that day at 7:30 a.m. Central time.
CME: 87.08 (-1.40)

Downgrade Alert for CME Group (CME)
Comtex SmarTrend(R) - Mon Dec 08, 7:00AM CST
CME Group (NYSE:CME) was downgraded from Outperform to Market Perform at Keefe Bruyette today. The stock closed yesterday at $88.74 on volume of 2.0 million shares, above average daily volume of 1.3 million. In the past 52 weeks, CME Group share prices have been bracketed by a low of $66.44 and a high of $88.88 and closed yesterday at $88.74, 34% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 0.6%.
CME: 87.08 (-1.40)

Exchange pair trade from KBW
Seeking Alpha - at Seeking Alpha - Mon Dec 08, 6:58AM CST

CME: 87.08 (-1.40), NDAQ: 46.11 (-0.86)

GFI Group Bidding War II: New Scenarios And Opportunities
Maudes Capital - at Seeking Alpha - Sun Dec 07, 4:45PM CST

GFIG: 5.39 (-0.11), CME: 87.08 (-1.40), BGCP: 8.51 (-0.33)

BGC Partners: A Dickensian Tale
Esekla - at Seeking Alpha - Fri Dec 05, 4:00AM CST

GFIG: 5.39 (-0.11), CME: 87.08 (-1.40), BGCP: 8.51 (-0.33)

What is Driving CME Group (CME) to the New 52-Week High? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 2:20PM CST
Shares of CME Group Inc. (CME) have scaled a new 52-week high at $86.80 on Dec 3, jumping 13.4% since the beginning of 2014.
GFIG: 5.39 (-0.11), CME: 87.08 (-1.40), CBOE: 62.34 (-1.19), ICE: 219.09 (-6.36)

Intercontinental Exchange joins swap futures battle
Seeking Alpha - at Seeking Alpha - Thu Dec 04, 11:57AM CST

CME: 87.08 (-1.40), ICE: 219.09 (-6.36)

Intercontinental Exchange Lists Five Contracts in Singapore - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 10:40AM CST
Intercontinental Exchange (ICE) will start its five futures contracts for trading at ICE Futures Singapore next year
CME: 87.08 (-1.40), CBOE: 62.34 (-1.19), MRKT: 25.58 (-0.74), ICE: 219.09 (-6.36)

2 Stocks to Benefit from Wild Oil Price Volatility in 2015
at The Street - Thu Dec 04, 10:14AM CST
Volatile oil prices have driven a surge in shares of CME Group and Intercontinental Exchange due to increased trading activity.
CME: 87.08 (-1.40), ICE: 219.09 (-6.36)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kearney's 2025 Global Cities Report Insights

Updated Category News Views 654

Global Cities Adapt to New Challenges and Emergence Global cities hold steady at the top as new hubs surge forward Top cities reaffirm their dominance in the Global Cities Index, showcasing remarkable resilience amidst global changes and uncertainties. The Global Cities Outlook indicates a noticeable shift as traditional leaders face turbulence, while emerging Gulf and...

Continue Reading
Vacca Family Law Group Enhances Support for Peaceful Divorce

Updated Category News Views 255

Empowering Families Through Non-Adversarial Divorce Solutions Families navigating the challenging process of separation now have renewed access to considerate and non-confrontational divorce options. Vacca Family Law Group has recently welcomed Attorney and Mediator Wendy Reimer, who brings nearly two decades of experience in family law and a strong background in...

Continue Reading
Ingredion Delivers Impressive Q3 Results, Upgrades Outlook

Updated Category News Views 55

Ingredion's Strong Performance in the Third Quarter Ingredion Incorporated (NYSE: INGR) has reported remarkable results for the third quarter of 2024, showcasing a noteworthy surge in both operating income and earnings per share (EPS). The global leader in ingredient solutions for the food and beverage industry achieved a stunning 26% increase in reported operating income...

Continue Reading
Insight into Learning Technologies Group Plc's Disclosure Mechanism

Updated Category News Views 193

Understanding the Public Opening Position Disclosure Process In the complex world of financial securities, understanding the disclosure requirements can feel daunting. However, the process outlined by the Takeover Code, particularly Rule 8.3, provides a structured approach for individuals and entities holding significant interests in relevant securities. This rule is...

Continue Reading
Avidity Biosciences Set to Inspire with Latest Presentations

Updated Category News Views 191

Avidity Biosciences' Key Presentations at the MDA Conference Avidity Biosciences, Inc. (Nasdaq: RNA), a pioneer in RNA therapeutics, is poised to make a significant impact at the upcoming Clinical and Scientific Conference organized by the Muscular Dystrophy Association (MDA). The event will showcase the latest advancements in the field and highlight groundbreaking...

Continue Reading